Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Norway / NCT07203469
Recruiting Not applicable

Where Wild Things Grow: Nature- and Activity-based Group Interventions for Neurodivergent Children and Youth

NCT07203469 · tracked via the Priya Life Science Norway tracker
Sponsor
Sorlandet Hospital HF
Phase
Not applicable
Started
2025-09-01
Last updated
2025-10-02

Condition(s) studied

Neurodevelopmental OutcomesADHD - Attention Deficit Disorder With HyperactivityAutismTourette SyndromeHealth-Related Quality-of-LifeHeart Rate Variability (HRV)

Investigational drug(s) / intervention(s)

Universal approachSelective approachOutdoor therapyClimbing therapy

Universal approach: In this intervention, the whole class participates in a 12-week nature-based experiential education program

Selective approach: In this intervention, an intentional group of pupils with an identified need is recruited from different classes within the same school to participate in a 12-week nature-based experiential education program

Outdoor therapy: This intervention is a 10-week outdoor therapy group treatment that takes place in nearby nature

Climbing therapy: This intervention is a 10-week climbing therapy group treatment that takes place indoors in a climbing hall

Study summary

The goal of this action research project is to develop and implement nature- and activity-based group interventions across health care, school and leisure settings in Southern Norway. The interventions are tailored to support the mental health, self-efficacy and daily life functioning of children and youth in the Agder region, with a particular focus on youngsters who struggle due to neurodivergence, such as Attention Deficit Hyperactivity Disorder (ADHD), Autism Spectrum Disorder (ASD) or Tourette's syndrome.

The main questions we aim to answer are:

1. To what extent does nature- and activity-based outdoor education contribute to improvements in children's quality of life?
2. To what extent does nature- and activity-based interventions in a health care setting improve children's self-efficacy, self-esteem and quality of life?
3. Is there a difference in physiological reactions between nature-based provision of education or therapy and traditional indoor provision of education or therapy?

Participants will take part in a 12-week school-based or health care intervention.

Eligibility

Sex
ALL
Min age
5 Years
Max age
18 Years
Healthy volunteers
Accepted
Inclusion Criteria: * In PhD 1, participants are recruited on class-level (all) or individual (identified need). * In PhD 2, inclusion criteria are patients that participate in the specific interventions. Exclusion Criteria: * In PhD 2, exclusion criteria include substance misuse, acute psychosis, current suicidal behavior/ideation, and severe eating disorders.

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Department of Child and Adolescent Mental Health (ABUP), Sørlandet Hospital HF Kristiansand Agder Recruiting
Department of Sport and Physical Education, University of Agder Kristiansand Agder Recruiting

More Sorlandet Hospital HF trials in Norway

Group-based ACT for Psychological Distress of Young People Recruiting
REACT MCI - Repeated Advanced Cognitive Training in Mild Cognitive Impairment Active, not recruiting
The Good Pain Consultation in Endometriosis. Recruiting
Surgical Approach in Hemiarthroplasty. A Randomized Clinical Trial Comparing Posterior and Anterior Approach Active, not recruiting
Establishing Mechanical Thrombectomy at a Limited-volume Stroke Center - Effects on Patient Morbidity and Mortality Recruiting

Other trials for the same condition

Online Video Training for Teachers to Improve Reading Skills in Children Using Augmentative and Alternative Communication Enrolling by invitation
Sensors for Communication for Persons Who Cannot Communicate Unequivocally Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07203469 on ClinicalTrials.gov ↗ ← All trials in Norway